AIMC Topic: Drug Discovery

Clear Filters Showing 1551 to 1560 of 1689 articles

Mol2Context-vec: learning molecular representation from context awareness for drug discovery.

Briefings in bioinformatics
With the rapid development of proteomics and the rapid increase of target molecules for drug action, computer-aided drug design (CADD) has become a basic task in drug discovery. One of the key challenges in CADD is molecular representation. High-qual...

Learning to SMILES: BAN-based strategies to improve latent representation learning from molecules.

Briefings in bioinformatics
Computational methods have become indispensable tools to accelerate the drug discovery process and alleviate the excessive dependence on time-consuming and labor-intensive experiments. Traditional feature-engineering approaches heavily rely on expert...

Molecular design in drug discovery: a comprehensive review of deep generative models.

Briefings in bioinformatics
Deep generative models have been an upsurge in the deep learning community since they were proposed. These models are designed for generating new synthetic data including images, videos and texts by fitting the data approximate distributions. In the ...

De novo generation of dual-target ligands using adversarial training and reinforcement learning.

Briefings in bioinformatics
Artificial intelligence, such as deep generative methods, represents a promising solution to de novo design of molecules with the desired properties. However, generating new molecules with biological activities toward two specific targets remains an ...

Comparative analysis of molecular fingerprints in prediction of drug combination effects.

Briefings in bioinformatics
Application of machine and deep learning methods in drug discovery and cancer research has gained a considerable amount of attention in the past years. As the field grows, it becomes crucial to systematically evaluate the performance of novel computa...

Deep fusion learning facilitates anatomical therapeutic chemical recognition in drug repurposing and discovery.

Briefings in bioinformatics
The advent of large-scale biomedical data and computational algorithms provides new opportunities for drug repurposing and discovery. It is of great interest to find an appropriate data representation and modeling method to facilitate these studies. ...

AniAMPpred: artificial intelligence guided discovery of novel antimicrobial peptides in animal kingdom.

Briefings in bioinformatics
With advancements in genomics, there has been substantial reduction in the cost and time of genome sequencing and has resulted in lot of data in genome databases. Antimicrobial host defense proteins provide protection against invading microbes. But c...

Utilizing graph machine learning within drug discovery and development.

Briefings in bioinformatics
Graph machine learning (GML) is receiving growing interest within the pharmaceutical and biotechnology industries for its ability to model biomolecular structures, the functional relationships between them, and integrate multi-omic datasets - amongst...

An effective self-supervised framework for learning expressive molecular global representations to drug discovery.

Briefings in bioinformatics
How to produce expressive molecular representations is a fundamental challenge in artificial intelligence-driven drug discovery. Graph neural network (GNN) has emerged as a powerful technique for modeling molecular data. However, previous supervised ...

A convolutional neural network and graph convolutional network-based method for predicting the classification of anatomical therapeutic chemicals.

Bioinformatics (Oxford, England)
MOTIVATION: The Anatomical Therapeutic Chemical (ATC) system is an official classification system established by the World Health Organization for medicines. Correctly assigning ATC classes to given compounds is an important research problem in drug ...